Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, DanielVolume:
8
Langue:
english
Journal:
Journal of Clinical Lipidology
DOI:
10.1016/j.jacl.2014.09.007
Date:
November, 2014
Fichier:
PDF, 527 KB
english, 2014
File converter
Plus de résultats de recherche
More benefits 
